Medicare Enrolled

Dr. Sheherbano Mehdi, M.D

Rheumatology · Torrance, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
23441 MADISON ST, Torrance, CA 90505
3103730340
In practice since 2008 (18 years)
NPI: 1437322971 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehdi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehdi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mehdi

Dr. Sheherbano Mehdi is a rheumatology specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mehdi performed 10,803 Medicare services across 640 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mehdi received a total of $13,783 from 34 pharmaceutical and/or device companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mehdi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 22% volume in CA $13,783 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,803
Medicare services
Top 22% in CA for rheumatology
640
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~600 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
6,608 $33 $71
Denosumab injection (Prolia/Xgeva) 2,589 $18 $28
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
508 $99 $174
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
197 $1 $25
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
189 $56 $140
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
145 $12 $42
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
137 $73 $141
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
117 $68 $92
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
89 $122 $240
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
80 $26 $90
New patient office visit, complex (60-74 min) 57 $181 $368
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
44 $57 $151
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
30 $158 $224
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
13 $42 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
65.6% high complexity
27.5% medium
6.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,783
Total received (2018-2024)
Avg $1,969/year across 7 years
Top 23% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
724
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,767 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,601
2023
$2,145
2022
$2,263
2021
$2,310
2020
$1,686
2019
$1,833
2018
$1,945

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$485
ABBVIE INC.
$399
Novartis Pharmaceuticals Corporation
$297
Fresenius Kabi USA, LLC
$155
AstraZeneca Pharmaceuticals LP
$144
UCB, Inc.
$40
Organon Llc
$30
Sandoz Inc.
$30
SCILEX PHARMACEUTICALS INC.
$23
Top 3 companies account for 73.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,577
Janssen Biotech, Inc.
$1,844
Novartis Pharmaceuticals Corporation
$1,296
ABBVIE INC.
$1,212
PFIZER INC.
$1,184
AbbVie Inc.
$648
Lilly USA, LLC
$549
AbbVie, Inc.
$465
Celgene Corporation
$432
AstraZeneca Pharmaceuticals LP
$391
UCB, Inc.
$387
GlaxoSmithKline, LLC.
$384
Aurinia Pharma U.S., Inc.
$357
GENZYME CORPORATION
$328
E.R. Squibb & Sons, L.L.C.
$289
Fresenius Kabi USA, LLC
$237
Organon LLC
$184
Genentech USA, Inc.
$148
Merck Sharp & Dohme Corporation
$145
Horizon Therapeutics plc
$121
Radius Health, Inc.
$120
MEDAC PHARMA, INC.
$66
Alexion Pharmaceuticals, Inc.
$61
Mallinckrodt Hospital Products Inc.
$57
Hikma Pharmaceuticals USA
$54
Flexion Therapeutics, Inc.
$48
Mallinckrodt LLC
$31
Organon Llc
$30
Sandoz Inc.
$30
Mallinckrodt Enterprises LLC
$28
SANOFI-AVENTIS U.S. LLC
$23
SCILEX PHARMACEUTICALS INC.
$23
Bioventus LLC
$19
Celltrion USA Inc.
$16
Top 3 companies account for 41.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · BENLYSTA · COSENTYX · Cimzia · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · Mitigare · ORENCIA · Otezla · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · STELARA · TALTZ · TREMFYA · Tymlos · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Torrance?
Compare rheumatologists in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
172
Per 100K population
1.7
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mehdi is a mixed practice specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mehdi experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Mehdi performed 6,608 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehdi receive payments from pharmaceutical companies?
Yes. Dr. Mehdi received a total of $13,783 from 34 companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehdi's costs compare to other rheumatologists in Torrance?
Dr. Mehdi's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehdi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →